Stay updated on Pembrolizumab for Metastatic Prostate Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for Metastatic Prostate Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for Metastatic Prostate Cancer Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov record for the pembrolizumab prostate cancer study is accessible, displaying its study overview, eligibility criteria, treatment plan, outcomes, and record details.
    Difference
    57%
    Check dated 2026-11-09T13:18:31.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer now displays revision v3.8.0 instead of v3.7.2.
    Difference
    0.2%
    Check dated 2026-11-02T12:57:28.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    A banner announces an NIH website transition and says agencies are using “Super Intelligence” in place of “Artificial Intelligence” during the transition.
    Difference
    1%
    Check dated 2026-10-26T14:57:19.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer now displays revision v3.7.2 instead of v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-19T14:44:41.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-12T14:52:49.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error, indicating access to the study record is blocked. The previous content and navigation for the record is replaced by an error page.
    Difference
    20%
    Check dated 2026-09-21T20:35:53.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for Metastatic Prostate Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Metastatic Prostate Cancer Clinical Trial page.